Molecular analysis of human T cell lymphotropic virus type 1 and 2 (HTLV-1/2) seroindeterminate blood donors from Northeast Iran: Evidence of proviral tax, env, and gag sequences

AIDS Research and Human Retroviruses

Volumn 27, Issue 2, 2011, Pages 131-135

  Zanjani, Delaram Sayadpour ^a   Shahabi, Majid ^b   Talaei, Nasim ^c   Afzalaghaee, Monavar ^d   Tehranian, Farahnaz ^a   Bazargani, Reihane ^a  

^a Mashhad Transfusion Service   (Iran)

^b IRANIAN BLOOD TRANSFUSION ORGANIZATION   (Iran)

^c Mashhad Health Clinic No 2   (Iran)

^d MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

GAG PROTEIN; POL PROTEIN; TAX PROTEIN; VIRUS ENVELOPE PROTEIN;

AMINO ACID SEQUENCE; ARTICLE; BLOOD DONOR; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; IRAN; MAJOR CLINICAL STUDY; MALE; NONHUMAN; OPTICAL DENSITY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROVIRUS; WESTERN BLOTTING;

BLOOD DONORS; BLOTTING, WESTERN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE PRODUCTS, ENV; GENE PRODUCTS, GAG; GENE PRODUCTS, TAX; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMAN T-LYMPHOTROPIC VIRUS 2; HUMANS; IRAN; MALE; POLYMERASE CHAIN REACTION;

EID: 79951687923     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2010.0017     Document Type: Article

References (24)

1. Mangano AM, Remesar M, Del Pozo A, and Sen L: Human T-cell lymphotropic virus types 1 and 2 proviral sequences in Argentinian blood donors with indeterminate Western blot patterns. J Med Virol 2004;74:323-327. (Pubitemid 39150400)
2. Rouet F, Meertens L, Courouble G, H-Strock C, Pabingui R, Chancerel B, et al.: Serological, epidemiological and molecular differences between human T-cell lymphotropic virus type 1 (HTLV-1)-seropositive healthy carriers and persons with HTLV-1 Gag indeterminate Western blot patterns from the Caribbean. J Clin Microb 2001;39(4):1247-1253. (Pubitemid 32275415)
3. Costa JMP and Segurado AC: Molecular evidence of human T-cell lymphotropic types 1 and 2 (HTLV-1 and HTLV-2) infections in HTLV seroindeterminate individuals from Sao Paulo, Brazil. J Clin Virol 2009;44:185-189.
4. Berini CA, Eirin ME, Pando MA, and Biglione MM: Human T-cell lymphotropic virus types 1 and 2 (HTLV-1 and-2) infection among seroindeterminate cases in Argentina. J Med Virol 2007;79:69-73. (Pubitemid 44902056)
5. Yao Karen, Hisada M, Maloney E, Yamano Y, Hanchard B, Wilks R, et al.: Human T lymphotropic virus types 1 and 2 Western blot seroindeterminate status and its association with exposure to prototype HTLV-I. JID 2006;193:427-437. (Pubitemid 43122343)
6. Koeing RE, Tolentino M, Taveras L, Ferro F, Zornoso C, Ferreiras J, et al.: Prevalence of HTLV infection in the Dominican Republic: Association with neurological disease. AIDS Res Hum Retroviruses 1992;8(2):221-226.
7. Safai B, Huang JL, Boeri E, Farid R, Raafat J, Schutzer P, et al.: Prevalence of HTLV type 1 infection in Iran: A serological and genetic study. AIDS Res Hum Retroviruses 1996;12(12):1185-90. (Pubitemid 26317422)
8. Abbaszadegan MR, Gholamian M, Tabatabaee A, Farid R, Houshmand M, and Abbaszadegan M: Prevalence of human T-lymphotropic virus type 1 among blood donors from Mashhad, Iran. J Clin Microbiol 2003;41(6):2593-2595. (Pubitemid 36712472)
9. Tarhini M, Kchour Gh, Sayadpour D, Rafatpanah H, Otrock ZK, Bazarbachi A, et al.: Declining tendency of human T-cell leukaemia virus type 1 carrier rates among blood donors in Mashhad, Iran. Pathology 2009;41(5):518-519.
10. Soldan SS, Graf MD, Waziri A, Flerlage AN, Robinson SM, Kawanishi T, et al.: HTLV-1/2 seroindeterminate Western blot reactivity in a cohort of patients with neurological diseases. JID 1999;180:685-694. (Pubitemid 29411353)
11. Mahieux R, Horal P, Mauclere P, M-Puijalon O, Guillotte M, Meertens L, et al.: Human T-cell lymphotropic virus type 1 Gag indeterminate Western blot patterns in Central Africa: Relationship to Plasmodium falciparum infection. J Clin Microbiol 2000;38(11):4049-4057. (Pubitemid 32233204)
12. Santos Tde J, Costa CM, Goubau P, Vandamme AM, Desmyter J, Van Doren S, et al.: Western blot seroindeterminate individuals for human T-lymphotropic virus 1/2 (HTLV-1/2) in Fortaleza (Brazil): A serological and molecular diagnostic and epidemiological approach. BJID 2003;7: 202-209.
13. Lal RB, Rudolph DL, Coligan JE, Brodine SK, and Roberts CR: Failure to detect evidence of human T-lymphotropic virus (HTLV) type 1 and 2 in blood donors with isolated gag antibodies to HTLV-1/2. Blood 1992;2:544-550.
14. Jacob F, Santos-Fortuna E, Azevedo RS, and Caterinode- Araujo A: Serological patterns and temporal trends of HTLV-1/2 infection in high-risk populations attending Public Health Units in Sao Paulo, Brazil. J Clin Virol 2008;42:149-155.
15. Cesaire R, Bera O, Maier H, Lezin A, Martial J, Ouka M, et al.: Seroindeterminate patterns and seroconversions to human T-lymphotropic virus type 1 positivity in blood donors from Martinique, French West Indies. Transfusion 1999; 39:1145-1149. (Pubitemid 29485333)
16. Mauclere P, Le Hesran JY, Mahieux R, Salla R, Mfoupouendoun J, Abada ET, et al.: Demographic, ethnic and geographic differences between human T-cell lymphotropic virus (HTLV) type 1-seropositive carriers and persons with HTLV-1 Gag-indeterminate Western blots in Central Africa. J Infect Dis 1997;176(2):505-509. (Pubitemid 27328776)
17. Lu SC and Chen BH: Seroindeterminate HTLV-1 prevalence and characteristics in blood donors in Taiwan. Int J Hematol 2003;77:412-413. (Pubitemid 37121842)
18. Porter KR, Liang L, Long GW, Bangs MJ, Anthony R, Anderson, et al.: Evidence for Plasmodium falciparum antibodies that cross-react with human T-lymphotropic virus type 1 proteins in a population in Irian Jaya, Indonesia. Clin Diagn Lab Immunol 1994;1(1):11-15. (Pubitemid 2036264)
19. Vandamme AM, Van Laethem K, Liu HF, Van Brussel M, Delaporte E, De Castro Costa CM, et al.: Use of a genetic polymerase chain reaction assay detecting human T-lymphotropic virus (HTLV) types 1, 2 and divergent simian strains in the evaluation of individuals with indeterminate HTLV serology. J Med Virol 1997;52:1-7. (Pubitemid 27243546)
20. Sato A, Isaka Y, Morita F, Ishii A, Goto Y, Imai J, et al.: Human sera from varicella-zoster-virus(VZV) infections cross-react with human T-cell leukaemia virus type 1 (HTLV-1): Common epitopes in VZV gene 22 protein and HTLV-1 p19 gag protein. J Gen Virol 1992;73:2969-2973.
21. Waziri A, Soldan SS, Graf MD, Nagle J, and Jacobson S: Characterization and sequencing of prototypic human Tlymphotropic virus type 1 (HTLV-1) from an HTLV-1/2 seroindeterminate patient. J Virol 2000;74(5):2178-2185. (Pubitemid 30091471)
22. Ramirez E, Fernandez J, Cartier L, Villota C, and Rios M: Defective human T-cell lymphotropic virus type 1 (HTLV-1) provirus in seronegative tropical spastic paraparesis/ HTLV-1-associated myelopathy (TSP/HAM) patients. Virus Res 2003;91(2):231-239. (Pubitemid 36165092)
23. Hall WW, Liu CR, Schneewind O, Takahashi H, Kaplan MH, Roupe G, et al.: Deleted HTLV-1 provirus in blood and cutaneous lesions of patients with mycosis fungoides. Science 1991;253(5017):317-320. (Pubitemid 21917157)
24. Kira J, Koyanagi Y, Yamada T, Itoyama Y, Tateishi J, Akizuki S, et al.: Sequence heterogeneity of HTLV-1 proviral DNA in the central nervous system of patients with HTLV-1 associated myelopathy. Ann Neurol 1994;36(2):149-156. (Pubitemid 24239231)